Fibrogen Inc., of San Francisco, appointed Aoife Brennan and Ben Cravatt to its board.

Okyo Pharma Ltd., of London, named James Khodabakhsh chair of its scientific advisory board.

Xortx Therapeutics Inc., of Calgary, Alberta, appointed David Sans director, corporate development.

No Comments